Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy-Reference-Cited by-同舟云学术

Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy

Published:2022-10-31 Issue:2 Volume:30 Page:204-210
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Yoshida Soichiro¹,Takahara Taro²³,Arita Yuki⁴^ORCID,Toda Kazuma⁵,Kimura Koichiro⁶,Fujiwara Motohiro¹^ORCID,Tanaka Hajime¹^ORCID,Yokoyama Minato¹^ORCID,Matsuoka Yoh¹^ORCID,Yoshimura Ryoichi⁵,Fujii Yasuhisa¹^ORCID

Affiliation:

1. Department of Urology Tokyo Medical and Dental University Tokyo Japan

2. Department of Biomedical Engineering Tokai University School of Engineering Kanagawa Japan

3. Department of Radiology Advanced Imaging Center, Yaesu Clinic Tokyo Japan

4. Department of Diagnostic Radiology Keio University School of Medicine Tokyo Japan

5. Department of Radiation Therapeutics and Oncology Tokyo Medical and Dental University Tokyo Japan

6. Department of Diagnostic Radiology Tokyo Medical and Dental University Tokyo Japan

Funder

Japan Society for the Promotion of Science London

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.15090

Reference24 articles.

1. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

2. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

3. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

4. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer

5. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer;Prostate International;2023-12

2. The role of prostate‐specific antigen changes in predicting overall survival after progressive‐site directed therapy for oligoprogressive castration‐resistant prostate cancer;International Journal of Urology;2023-03-31